MX2007011665A - Terapeutico para influenza. - Google Patents

Terapeutico para influenza.

Info

Publication number
MX2007011665A
MX2007011665A MX2007011665A MX2007011665A MX2007011665A MX 2007011665 A MX2007011665 A MX 2007011665A MX 2007011665 A MX2007011665 A MX 2007011665A MX 2007011665 A MX2007011665 A MX 2007011665A MX 2007011665 A MX2007011665 A MX 2007011665A
Authority
MX
Mexico
Prior art keywords
rnai
influenza
inducing
influenza virus
provides
Prior art date
Application number
MX2007011665A
Other languages
English (en)
Spanish (es)
Inventor
Jianzhu Chen
Herman N Eisen
Qing Ge
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/102,097 external-priority patent/US20060160759A1/en
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Publication of MX2007011665A publication Critical patent/MX2007011665A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2007011665A 2005-03-22 2006-03-22 Terapeutico para influenza. MX2007011665A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66458005P 2005-03-22 2005-03-22
US11/102,097 US20060160759A1 (en) 2002-09-28 2005-04-08 Influenza therapeutic
PCT/US2006/010491 WO2006102461A2 (en) 2005-03-22 2006-03-22 Influenza therapeutic

Publications (1)

Publication Number Publication Date
MX2007011665A true MX2007011665A (es) 2007-11-14

Family

ID=39406020

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007011665A MX2007011665A (es) 2005-03-22 2006-03-22 Terapeutico para influenza.

Country Status (5)

Country Link
JP (1) JP2008533990A (https=)
CN (1) CN101180395A (https=)
IL (1) IL186057A0 (https=)
MX (1) MX2007011665A (https=)
NO (1) NO20074929L (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103966213A (zh) * 2013-02-06 2014-08-06 霍晋 A型流感病毒M基因有干扰作用的siRNA序列的设计和干扰作用的鉴定
CN103966212A (zh) * 2013-02-06 2014-08-06 霍晋 A型流感病毒NP基因有干扰作用的siRNA序列的设计及应用
CN103966214A (zh) * 2013-02-06 2014-08-06 霍晋 A型流感病毒PB基因有干扰作用的siRNA序列的设计及应用
RU2716420C2 (ru) * 2013-06-17 2020-03-11 Те Брод Инститьют Инк. Доставка и применение систем crispr-cas, векторов и композиций для целенаправленного воздействия и терапии в печени
CN106132206B (zh) * 2014-01-23 2020-11-13 科罗拉多州立大学研究基金会 鸡禽流感的大肠杆菌介导的siRNA沉默
CN106381296A (zh) * 2015-11-19 2017-02-08 中国农业科学院哈尔滨兽医研究所 表达多基因抗流感转基因动物的构建方法
CN106947763B (zh) * 2017-03-20 2019-11-12 中国医学科学院医药生物技术研究所 可雾化吸入的抗流感病毒感染的siRNA及其应用
US11931416B2 (en) 2019-02-01 2024-03-19 The Board Of Trustees Of The Leland Stanford Junior University Immolative cell-penetrating complexes for nucleic acid delivery to the lung
US12589161B2 (en) * 2019-07-10 2026-03-31 The University Of Hong Kong PEGylated synthetic KL4 peptide, compositions and methods thereof

Also Published As

Publication number Publication date
NO20074929L (no) 2007-12-18
JP2008533990A (ja) 2008-08-28
IL186057A0 (en) 2008-01-20
CN101180395A (zh) 2008-05-14

Similar Documents

Publication Publication Date Title
WO2006102461A3 (en) Influenza therapeutic
Ji et al. NS1: a key protein in the “game” between influenza A virus and host in innate immunity
Zhang et al. Induction of the cellular miR-29c by influenza virus inhibits the innate immune response through protection of A20 mRNA
NO20074929L (no) Influensa terapeutisk middel
Selvamani et al. Chikungunya virus exploits miR-146a to regulate NF-κB pathway in human synovial fibroblasts
MX385869B (es) Agentes de iarn modificados.
BR112021019880A2 (pt) Terapias gênicas para distúrbios lisossomais
MX2024005653A (es) Agentes de acido ribonucleico (arn) de cadena doble modificados.
JP2010505897A (ja) インフルエンザターゲット
WO2015106128A3 (en) Rnai agents modified at the 4'-c-position
JP2019508045A (ja) がんを処置するための組み合わせベクターおよび方法
JP2024500036A (ja) 抱合体
Ouyang et al. gga-miR-2127 downregulates the translation of chicken p53 and attenuates chp53-mediated innate immune response against IBDV infection
US20110184045A1 (en) Silencng and rig-i activation by dual function oligonucleotides
BR112019009953A2 (pt) substâncias direcionadas a vários órgãos ou tecidos selecionados
EP3672579A2 (en) Compositions and methods for treating age-related macular degeneration and geographic atrophy
Stoppani et al. Expression of a single siRNA against a conserved region of NP gene strongly inhibits in vitro replication of different Influenza A virus strains of avian and swine origin
KR101638156B1 (ko) C형 간염 바이러스 감염 질환의 예방 또는 치료용 약학 조성물
RU2016131028A (ru) Композиции, содержащие асимметричную интерферирующую рнк, которые подвергают сайленсингу k-ras, и способы их применения
Stewart et al. Immunostimulatory motifs enhance antiviral siRNAs targeting highly pathogenic avian influenza H5N1
Yuan et al. A RNAi-based strategy to suppress Micropterus salmoides rhabdovirus in GCO cells and largemouth bass by silencing envelope glycoprotein
Talari et al. MicroRNA-712 restrains macrophage pro-inflammatory responses by targeting LRRK2 leading to restoration of insulin stimulated glucose uptake by myoblasts
JP4054844B2 (ja) 副作用のないRNAi医薬
JP7639035B2 (ja) 骨量減少または筋機能低下に関連する病的状態を治療する際に使用するためのマイクロrna19a/19b
KR101783444B1 (ko) miR-33-5p 를 이용한 뇌신경세포 보호 물질 스크리닝 방법

Legal Events

Date Code Title Description
FA Abandonment or withdrawal